                               SEQUENCE LISTING                               

<110> ARLINGHAUS, RALPH B.
      XIE, SHANHAI
      LIN, HUI
      SUN, TONG

<120> TARGETING A SECRETED PRO-APOPTOTIC FACTOR FOR CANCER
      THERAPEUTICS

<130> UTFC:919WO

<140> UNKNOWN
<141> 2006-02-10

<150> 60/651,877
<151> 2005-02-10

<160> 9                             

<170> PatentIn Ver. 2.1

<210> 1
<211> 58
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:  Synthetic
      Primer

<400> 1
ggcagcttta cgatgtacat tcaagagatg tacatcgtaa agctgccttt tttccaat   58    


<210> 2
<211> 58
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:  Synthetic
      Primer

<400> 2
catttgttcc aagctccagt tcaagagact ggagcttgga acaaatgttt tttccaat   58    


<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:  Synthetic
      Primer

<400> 3
agccagactt ccggagcgat c                                           21    


<210> 4
<211> 22
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:  Synthetic
      Primer

<400> 4
acttggcaaa gcgggtgaaa cg                                          22    


<210> 5
<211> 20
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:  Synthetic
      Primer

<400> 5
cctggcaggc aatgcggtcc                                             20    


<210> 6
<211> 19
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:  Synthetic
      Primer

<400> 6
gggcaggtgg tacgttgtg                                              19    


<210> 7
<211> 24
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence:  Synthetic
      Primer

<400> 7
cgtaaagctg ccttctgttt tttt                                        24    


<210> 8
<211> 845
<212> DNA
<213> Homo sapiens

<400> 8
caggtgagcc tctcactcgc cacctcctct tccacccctg ccaggcccag cagccaccac 60    
agcgcctgct tcctcggccc tgaaatcatg cccctaggtc tcctgtggct gggcctagcc 120   
ctgttggggg ctctgcatgc ccaggcccag gactccacct cagacctgat cccagcccca 180   
cctctgagca aggtccctct gcagcagaac ttccaggaca accaattcca ggggaagtgg 240   
tatgtggtag gcctggcagg gaatgcaatt ctcagagaag acaaagaccc gcaaaagatg 300   
tatgccacca tctatgagct gaaagaagac aagagctaca atgtcacctc cgtcctgttt 360   
aggaaaaaga agtgtgacta ctggatcagg acttttgttc caggttgcca gcccggcgag 420   
ttcacgctgg gcaacattaa gagttaccct ggattaacga gttacctcgt ccgagtggtg 480   
agcaccaact acaaccagca tgctatggtg ttcttcaaga aagtttctca aaacagggag 540   
tacttcaaga tcaccctcta cgggagaacc aaggagctga cttcggaact aaaggagaac 600   
ttcatccgct tctccaaatc tctgggcctc cctgaaaacc acatcgtctt ccctgtccca 660   
atcgaccagt gtatcgacgg ctgagtgcac aggtgccgcc agctgccgca ccagcccgaa 720   
caccattgag ggagctggga gaccctcccc acagtgccac ccatgcagct gctccccagg 780   
ccaccccgct gatggagccc caccttgtct gctaaataaa catgtgccct caggccaaaa 840   
agaaa                                                             845   


<210> 9
<211> 198
<212> PRT
<213> Homo sapiens

<400> 9
Met Pro Leu Gly Leu Leu Trp Leu Gly Leu Ala Leu Leu Gly Ala Leu  
  1               5                  10                  15    

His Ala Gln Ala Gln Asp Ser Thr Ser Asp Leu Ile Pro Ala Pro Pro  
             20                  25                  30        

Leu Ser Lys Val Pro Leu Gln Gln Asn Phe Gln Asp Asn Gln Phe Gln  
         35                  40                  45            

Gly Lys Trp Tyr Val Val Gly Leu Ala Gly Asn Ala Ile Leu Arg Glu  
     50                  55                  60                

Asp Lys Asp Pro Gln Lys Met Tyr Ala Thr Ile Tyr Glu Leu Lys Glu  
 65                  70                  75                  80

Asp Lys Ser Tyr Asn Val Thr Ser Val Leu Phe Arg Lys Lys Lys Cys  
                 85                  90                  95    

Asp Tyr Trp Ile Arg Thr Phe Val Pro Gly Cys Gln Pro Gly Glu Phe  
            100                 105                 110        

Thr Leu Gly Asn Ile Lys Ser Tyr Pro Gly Leu Thr Ser Tyr Leu Val  
        115                 120                 125            

Arg Val Val Ser Thr Asn Tyr Asn Gln His Ala Met Val Phe Phe Lys  
    130                 135                 140                

Lys Val Ser Gln Asn Arg Glu Tyr Phe Lys Ile Thr Leu Tyr Gly Arg  
145                 150                 155                 160

Thr Lys Glu Leu Thr Ser Glu Leu Lys Glu Asn Phe Ile Arg Phe Ser  
                165                 170                 175    

Lys Ser Leu Gly Leu Pro Glu Asn His Ile Val Phe Pro Val Pro Ile  
            180                 185                 190        

Asp Gln Cys Ile Asp Gly                                          
        195            


